Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)
Clinical trial NCT04054193 · COMPLETED
Trial details
- NCT number
- NCT04054193
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-09
- Primary completion
- 2021-02-11
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.